Current Opinion in Neurology最新文献

筛选
英文 中文
Novel therapies for glioblastoma. 胶质母细胞瘤的新疗法。
IF 4.7 2区 医学
Current Opinion in Neurology Pub Date : 2026-12-01 Epub Date: 2026-10-20 DOI: 10.1097/WCO.0000000000001519
Sneha R Gupta, Karisa C Schreck
{"title":"Novel therapies for glioblastoma.","authors":"Sneha R Gupta, Karisa C Schreck","doi":"10.1097/WCO.0000000000001519","DOIUrl":"10.1097/WCO.0000000000001519","url":null,"abstract":"<p><strong>Purpose of review: </strong>Glioblastoma is the most aggressive and treatment-resistant primary brain tumor in adults. Given its clinical severity and biological complexity, research efforts are focused on understanding and targeting intratumoral heterogeneity, adaptive resistance, drug delivery barriers, and the immunosuppressive tumor microenvironment. This review highlights emerging therapeutic approaches for the treatment of glioblastoma including advances in radiation planning, molecularly targeted therapy, immunotherapy, blood-brain barrier modulation, and neuronal signaling.</p><p><strong>Recent findings: </strong>Radiation therapy remains a cornerstone of glioblastoma treatment, and advances in image-guided planning are being developed to refine treatment margins and improve tolerability without compromising efficacy. Blood-brain barrier permeability is being improved through device-assisted approaches, including focused ultrasound in combination with systemic therapies. Molecularly targeted and immunotherapeutic approaches continue to be evaluated, increasingly with biomarker-informed strategies to optimize patient selection. In parallel, drug repurposing, neuronal modulation, and metabolic interventions have shown promising preclinical and retrospective signals and are moving towards prospective studies. Interventions to improve quality of life are also underway with early palliative care showing significant impact for patients with glioblastoma.</p><p><strong>Summary: </strong>As the field moves towards tailored and precision-guided approaches, combination strategies remain central to addressing the multiple mechanisms by which glioblastoma evades treatment.</p>","PeriodicalId":11059,"journal":{"name":"Current Opinion in Neurology","volume":" ","pages":"564-570"},"PeriodicalIF":4.7,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149220081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent advances in multiple sclerosis neurorehabilitation. 多发性硬化症神经康复的最新进展。
IF 4.7 2区 医学
Current Opinion in Neurology Pub Date : 2026-12-01 Epub Date: 2026-10-26 DOI: 10.1097/WCO.0000000000001529
Roshan das Nair, Sarah Donkers, Helen L Ford, Giampaolo Brichetto
{"title":"Recent advances in multiple sclerosis neurorehabilitation.","authors":"Roshan das Nair, Sarah Donkers, Helen L Ford, Giampaolo Brichetto","doi":"10.1097/WCO.0000000000001529","DOIUrl":"10.1097/WCO.0000000000001529","url":null,"abstract":"<p><strong>Purpose of review: </strong>Advances in multiple sclerosis (MS) diagnosis and treatment have altered disease trajectories, yet many people with MS (pwMS) continue to experience complex symptom burden, functional limitations, and reduced quality of life (QoL). This review summarizes recent developments in neurorehabilitation, focusing on screening and assessment, intervention delivery, and outcome or impact evaluation across symptoms and disability domains.</p><p><strong>Recent findings: </strong>Research evidence supports routine, multidimensional screening that goes beyond assessing symptom severity to capture functional limitations, participation restrictions, and social determinants of health (SDoH). Digital technologies, including wearables, remote monitoring, and artificial intelligence-assisted assessments, offer opportunities for more ecologically valid and accessible evaluation, although usability, digital exclusion, and implementation issues remain. Neurorehabilitation is increasingly viewed as a treatment that should begin early in the disease course rather than being reserved for advanced disability. Exercise interventions, cognitive rehabilitation, psychological therapies, vocational rehabilitation, and integrated multidisciplinary approaches demonstrate benefits across physical, cognitive, emotional, fatigue, and QoL outcomes. Telerehabilitation and technology-supported interventions, including virtual reality, exergaming, and neuromodulation, show promise in improving access and outcomes, but more research is needed. To sustain long-term neurorehabilitation benefits, teaching self-management strategies and brain-health behaviours may be beneficial.</p><p><strong>Summary: </strong>Neurorehabilitation is a core component of comprehensive MS care, complementing pharmacological treatment. Evidence favours early, personalized, function-focused interventions delivered through flexible, tiered, and multidisciplinary models. Research gaps include implementation of screening pathways, optimization of person-to-treatment matching and dosing, integration of SDoH, development of meaningful patient-centred outcomes, evaluation of cost-effectiveness, and improved equity of access to rehabilitation services and research across diverse populations.</p>","PeriodicalId":11059,"journal":{"name":"Current Opinion in Neurology","volume":" ","pages":"531-537"},"PeriodicalIF":4.7,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149264052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial. 社论。
IF 4.7 2区 医学
Current Opinion in Neurology Pub Date : 2026-12-01 Epub Date: 2026-11-05 DOI: 10.1097/WCO.0000000000001533
Patrick Y Wen, Vihang Nakhate
{"title":"Editorial.","authors":"Patrick Y Wen, Vihang Nakhate","doi":"10.1097/WCO.0000000000001533","DOIUrl":"https://doi.org/10.1097/WCO.0000000000001533","url":null,"abstract":"","PeriodicalId":11059,"journal":{"name":"Current Opinion in Neurology","volume":"39 6","pages":"553-554"},"PeriodicalIF":4.7,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liquid biopsy for brain tumors. 脑肿瘤液体活检。
IF 4.7 2区 医学
Current Opinion in Neurology Pub Date : 2026-12-01 Epub Date: 2026-11-05 DOI: 10.1097/WCO.0000000000001522
Saiesha Nooguru, Jose Ricardo McFaline-Figueroa
{"title":"Liquid biopsy for brain tumors.","authors":"Saiesha Nooguru, Jose Ricardo McFaline-Figueroa","doi":"10.1097/WCO.0000000000001522","DOIUrl":"https://doi.org/10.1097/WCO.0000000000001522","url":null,"abstract":"<p><strong>Purpose of review: </strong>Diagnosis and molecular classification of central nervous system (CNS) tumors depend largely on neurosurgical sampling, which may be difficult to obtain and is rarely repeated throughout the disease course. This review examines how liquid biopsy may extend molecular assessment of primary and metastatic CNS tumors beyond the initial tissue specimen.</p><p><strong>Recent findings: </strong>Cerebrospinal fluid (CSF) cell-free DNA can identify diagnostically informative alterations in gliomas, CNS lymphoma, and CNS metastases. Serial sampling can reveal evolving tumor clones and resistance-associated alterations absent from archival tissue. Recent advances in error-corrected sequencing, fragment analysis, and methylation classification broaden the molecular information available from blood and CSF. However, diagnostic yield varies with tumor type, anatomical location, sampling compartment, and assay design, and blood-based detection remains challenging in primary brain tumors.</p><p><strong>Summary: </strong>Liquid biopsy may complement tissue diagnosis, imaging, and conventional CSF studies, particularly when repeat tissue sampling is impractical. Prospective validation is needed to establish standardized workflows, clarify the interpretation of negative results, and determine whether molecular findings improve treatment selection and patient outcomes.</p>","PeriodicalId":11059,"journal":{"name":"Current Opinion in Neurology","volume":"39 6","pages":"597-605"},"PeriodicalIF":4.7,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychopharmacological advances in neurorehabilitation after traumatic brain injury. 创伤性脑损伤后神经康复的精神药理学研究进展。
IF 4.7 2区 医学
Current Opinion in Neurology Pub Date : 2026-12-01 Epub Date: 2026-10-26 DOI: 10.1097/WCO.0000000000001528
Vincent Arcani, Charles Iruthayanathar, Katrin Rauen
{"title":"Psychopharmacological advances in neurorehabilitation after traumatic brain injury.","authors":"Vincent Arcani, Charles Iruthayanathar, Katrin Rauen","doi":"10.1097/WCO.0000000000001528","DOIUrl":"10.1097/WCO.0000000000001528","url":null,"abstract":"<p><strong>Purpose of review: </strong>Pharmacotherapy is widely used to manage neuropsychiatric sequelae that may interfere with neurorehabilitation after traumatic brain injury (TBI), despite limited TBI-specific evidence. This review summarizes psychopharmacological evidence from the past 18 months and proposes a three-step approach: deprescribing potentially recovery-limiting medications, characterizing individual neuropsychiatric symptoms, and selecting symptom-targeted treatments to support cognitive, emotional, behavioral, and functional recovery after TBI.</p><p><strong>Recent findings: </strong>Methylphenidate shows the most consistent evidence for selected cognitive outcomes, particularly attention and processing speed. Pharmacological approaches to agitation, sleep-wake disorders, depression, fatigue, and posttraumatic headache have been studied, but TBI-specific evidence remains limited or heterogeneous. Sedative, anticholinergic, and cognitive adverse effects, cardiovascular risks, and dependence require consideration in TBI neurorehabilitation.</p><p><strong>Summary: </strong>No pharmacological treatment is established as disease-modifying after TBI. Given the limited evidence, psychopharmacotherapy should be individualized, symptom-targeted, and integrated into multidisciplinary TBI neurorehabilitation. Continuous medication review and deprescribing should accompany careful treatment selection and monitoring. Future trials should determine whether symptom improvement translates into better rehabilitation participation, functional independence, and long-term health-related quality of life.</p>","PeriodicalId":11059,"journal":{"name":"Current Opinion in Neurology","volume":" ","pages":"522-530"},"PeriodicalIF":4.7,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149264022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunotherapy for gliomas: from checkpoint blockade to vaccines, cellular therapy, local immune engineering and combinations. 神经胶质瘤的免疫治疗:从检查点阻断到疫苗、细胞治疗、局部免疫工程和组合。
IF 4.7 2区 医学
Current Opinion in Neurology Pub Date : 2026-12-01 Epub Date: 2026-11-05 DOI: 10.1097/WCO.0000000000001524
Elizabeth Owens, Maya S Chandar, Mustafa Khasraw
{"title":"Immunotherapy for gliomas: from checkpoint blockade to vaccines, cellular therapy, local immune engineering and combinations.","authors":"Elizabeth Owens, Maya S Chandar, Mustafa Khasraw","doi":"10.1097/WCO.0000000000001524","DOIUrl":"https://doi.org/10.1097/WCO.0000000000001524","url":null,"abstract":"<p><strong>Purpose of review: </strong>Immunotherapy has transformed the treatment of many malignancies but has not yet produced comparable improvements in survival for patients with gliomas. This review examines the biological rationale for immunotherapy across molecularly defined gliomas, lessons from unsuccessful immune checkpoint inhibitor trials, and emerging strategies including vaccines, adoptive cellular therapies, bispecific T-cell engagers, immunocytokines, innate immune modulators, oncolytic viruses, and approaches to improve delivery within the central nervous system.</p><p><strong>Recent findings: </strong>Randomized studies have established that programmed death-1 (PD-1) blockade alone is insufficient for unselected patients with glioblastoma. Treatment resistance reflects multiple interacting barriers, including low and heterogeneous antigen expression, limited T-cell infiltration, T-cell dysfunction, immunosuppressive myeloid populations, corticosteroid exposure, and treatment-associated lymphopenia. Importantly, these features differ across glioma subtypes. Recent studies demonstrate that vaccines directed against clonal IDH1 and H3K27M mutations can generate durable antigen-specific immunity, while locoregionally delivered chimeric antigen receptor T (CAR-T) cells targeting IL13Rα2, EGFR/EGFRvIII, GD2, and B7-H3 can produce rapid and occasionally durable tumor regression. Oncolytic viruses and immunocytokines provide complementary approaches to remodeling the glioma microenvironment.</p><p><strong>Summary: </strong>The principal challenge in glioma immunotherapy is no longer demonstrating that immune cells can recognize and kill glioma cells but converting immune recognition into durable tumor control. Future progress will likely depend on matching therapy to molecular subtype, targeting multiple or clonal antigens, optimizing immune-cell trafficking and persistence, modifying the suppressive microenvironment, and longitudinally monitoring tumor and immune evolution.</p>","PeriodicalId":11059,"journal":{"name":"Current Opinion in Neurology","volume":"39 6","pages":"571-577"},"PeriodicalIF":4.7,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The blood-brain barrier and strategies for drug delivery to brain tumors. 血脑屏障和脑肿瘤药物输送策略。
IF 4.7 2区 医学
Current Opinion in Neurology Pub Date : 2026-12-01 Epub Date: 2026-11-05 DOI: 10.1097/WCO.0000000000001521
Vihang Nakhate, Patrick Y Wen
{"title":"The blood-brain barrier and strategies for drug delivery to brain tumors.","authors":"Vihang Nakhate, Patrick Y Wen","doi":"10.1097/WCO.0000000000001521","DOIUrl":"https://doi.org/10.1097/WCO.0000000000001521","url":null,"abstract":"<p><strong>Purpose of review: </strong>Drug delivery across the blood-brain barrier (BBB) remains an important challenge in the treatment of brain tumors. This review summarizes the physiologic barriers to effective CNS drug exposure and evaluates strategies to improve delivery, with a focus on glioma.</p><p><strong>Recent findings: </strong>Recent advances span three complementary approaches: engineering therapeutics for BBB penetration, transient BBB disruption, and locoregional delivery to bypass the BBB. Modern medicinal chemistry has enabled highly brain-penetrant agents such as vorasidenib, while transporter/receptor-mediated and nanocarrier platforms remain under investigation. Ultrasound with microbubbles has emerged as a leading strategy for spatially targeted, reversible BBB disruption, with early clinical studies demonstrating increased delivery of chemotherapies and monoclonal antibodies. Convection-enhanced delivery has benefited from improved catheter design, image guidance, and implantable systems, although efficacy in brain tumors remains unproven. Intratumoral oncolytic viruses and CSF-based cellular therapies are additional emerging approaches.</p><p><strong>Summary: </strong>Strategies for drug delivery to brain tumors have advanced substantially, but translation remains challenging. Efficacious therapies must not only overcome the BBB but also achieve adequate exposure and target engagement across heterogeneous tumor regions. Future studies must pair active therapeutics with relevant delivery strategies, ascertain drug exposure and target engagement early through window-of-opportunity studies, and evaluate efficacy in randomized trials.</p>","PeriodicalId":11059,"journal":{"name":"Current Opinion in Neurology","volume":"39 6","pages":"586-596"},"PeriodicalIF":4.7,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The cognitive and technological era in neurorehabilitation. 神经康复的认知与技术时代。
IF 4.7 2区 医学
Current Opinion in Neurology Pub Date : 2026-12-01 Epub Date: 2026-11-05 DOI: 10.1097/WCO.0000000000001531
Arseny A Sokolov
{"title":"The cognitive and technological era in neurorehabilitation.","authors":"Arseny A Sokolov","doi":"10.1097/WCO.0000000000001531","DOIUrl":"https://doi.org/10.1097/WCO.0000000000001531","url":null,"abstract":"","PeriodicalId":11059,"journal":{"name":"Current Opinion in Neurology","volume":"39 6","pages":"499-503"},"PeriodicalIF":4.7,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The electrical life of cancer: cancer neuroscience from circuits to patient care. 癌症的电生命:从电路到病人护理的癌症神经科学。
IF 4.7 2区 医学
Current Opinion in Neurology Pub Date : 2026-12-01 Epub Date: 2026-10-20 DOI: 10.1097/WCO.0000000000001517
Matilde Pittarello, Abraham Dada, Shawn L Hervey-Jumper
{"title":"The electrical life of cancer: cancer neuroscience from circuits to patient care.","authors":"Matilde Pittarello, Abraham Dada, Shawn L Hervey-Jumper","doi":"10.1097/WCO.0000000000001517","DOIUrl":"10.1097/WCO.0000000000001517","url":null,"abstract":"<p><strong>Purpose of review: </strong>Cancer neuroscience has evolved from a predominantly preclinical, mechanistic discipline into a clinically relevant framework for understanding and treating patients with brain malignancies. This review synthesizes recent advances across glioblastoma (GBM), diffuse midline glioma (DMG), and brain metastases, with particular emphasis on identifying circuit-level, neurotransmitter-mediated, electrophysiologic, and network properties that are emerging as clinically actionable biomarkers and therapeutic targets.</p><p><strong>Recent findings: </strong>Human connectomics and retrograde tracing studies demonstrate that GBM integrates into distributed, brain-wide neural circuits. In DMG, neuron-tumor signaling has expanded beyond glutamatergic mechanisms to include GABAergic and cholinergic neurotransmission, while patterns of neural connectivity have been associated with regional immunosuppression and patient survival. Patch-seq and electrophysiologic profiling have identified distinct functional states of malignant cells, and spatial transcriptomic analyses have linked malignant cell plasticity to neuron-rich invasive niches. Although these discoveries are driving the development of neurophysiologic biomarkers and circuit-directed therapeutic strategies, they have not yet translated into clinical practice. Emerging cellular atlases and mechanistic studies of small cell lung cancer and brain metastases further suggest that neural circuit integration is a broader feature of cancer biology rather than a phenomenon restricted to gliomas.</p><p><strong>Summary: </strong>The field's critical next step is to integrate cancer neuroscience-directed therapeutic strategies with prospectively validated, multimodal biomarkers that account for age and disease-specific neurobiology and reliably distinguish tumor associated states from physiologic aging and adaptive changes within the peritumoral microenvironment.</p>","PeriodicalId":11059,"journal":{"name":"Current Opinion in Neurology","volume":" ","pages":"578-585"},"PeriodicalIF":4.7,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149220045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cognitive training for mild neurocognitive disorder: a review of recent evidence and emerging directions. 轻度神经认知障碍的认知训练:最近的证据和新兴方向的回顾。
IF 4.7 2区 医学
Current Opinion in Neurology Pub Date : 2026-12-01 Epub Date: 2026-10-26 DOI: 10.1097/WCO.0000000000001525
Sylvie Belleville, Petter Espeseth Emhjellen, Stella Ruddy
{"title":"Cognitive training for mild neurocognitive disorder: a review of recent evidence and emerging directions.","authors":"Sylvie Belleville, Petter Espeseth Emhjellen, Stella Ruddy","doi":"10.1097/WCO.0000000000001525","DOIUrl":"10.1097/WCO.0000000000001525","url":null,"abstract":"<p><strong>Purpose of review: </strong>Older adults with mild neurocognitive disorder (MND), also referred to as mild cognitive impairment, exhibit measurable cognitive deficits while maintaining a relatively preserved autonomy, but are at increased dementia risk. Because learning capacity and neuroplasticity remain substantial during this stage, MND represents an important window for intervention. Cognitive training is increasingly studied in this population and encompasses a broad range of interventions designed to enhance cognitive function through either the repeated practice of targeted tasks (process-based approaches) or instruction of specific strategies (strategy-based approaches).</p><p><strong>Recent findings: </strong>This review synthesizes recent evidence on cognitive training in MND focusing on: its efficacy and long-term effects; transfer effects to untrained cognitive tasks, everyday functioning, and psychological symptoms; intervention and participant characteristics associated with treatment response; mechanisms of action investigated using functional neuroimaging; and feasibility and implementation outcomes.</p><p><strong>Summary: </strong>Cognitive training is promising for MND. It produces reliable short-term cognitive benefits, and although evidence for long-term effects on cognitive and clinical trajectory remain limited, findings from recent studies are encouraging. Future research should prioritize meaningful transfer to everyday functioning, identification of moderators and responders, and the optimization of implementation strategies across intervention types.</p>","PeriodicalId":11059,"journal":{"name":"Current Opinion in Neurology","volume":" ","pages":"538-545"},"PeriodicalIF":4.7,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149264046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书